Lilak v. Takeda Pharmaceutical North America, INC. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Lilak v. Takeda Pharmaceutical North America, INC.

Sort by

Viewing results 1‒25 of 116

Companies
Prospering in the pandemic: 2020’s top 100 companies
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
January 1, 2021
Jonathan Guthrie
The fallacy behind the rise of passive fund management
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
January 15, 2020
FT Live
Innovative Lawyers Awards North America
Celebrating innovations from both law firms and in-house teams in the region
Monday, 9 DecemberGotham Hall, Broadway, New York, NY, USA
US & Canadian companies
Japan’s Renesas to acquire US rival IDT in $7.2bn deal
...The latest acquisition contributes to a record year for Japanese outbound deals, led by Takeda Pharmaceutical’s £46bn agreement to buy Irish drugmaker Shire in April....
September 11, 2018
News in-depthWeek in Review
Week in review, March 31
...Others focused on the significance of Takeda’s move for its country’s pharmaceuticals industry....
March 30, 2018
News in-depthCurrencies
Global M&A activity hits new high
...Corporate giants including US cable group Comcast, wireless provider T-Mobile and Japan’s pharmaceutical maker Takeda reached for M&A to head off competitive threats and expand their businesses....
September 28, 2018
Mergers & Acquisitions
Praxair sells $6bn in European assets to Japan’s Taiyo
...The European gas market was “stable”, Taiyo said, noting it was second in size only to North America....
July 5, 2018
FT Live
Future of Asset Management North America
New models for the next age of fund management
Wednesday, 25 SeptemberNew York, NY, USA
News in-depthThe Big Read
Quantum computing: the power to think outside the box
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
September 3, 2018
Health sector
Hikma Pharma dims generics outlook again after May cut
...Separately, Hikma disclosed on Thursday that it will expand its licensing and distribution pact with Japan’s Takeda Pharmaceuticals that will add new products to its Middle East and North Africa portfolio...
August 17, 2017
News in-depthThe Big Read
Big Tech vs Big Pharma: the battle over US patent protection
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
October 16, 2017
US politics & policy
Big US pharma dealmaking plunges to five-year low
...Thomas Sheehan, head of global healthcare at Bank of America Merrill Lynch, said despite the slowdown the fundamentals for dealmaking remained unchanged and activity was bound to pick up again....
June 12, 2017
Pharmaceuticals sector
Health care stocks fall after Trump comments on drug pricing
...Cancer drug maker Takeda Pharmaceutical, fell 2.6 per cent following Trump’s comments....
January 12, 2017
US politics & policy
Drug stocks tumble as Trump singles out pharma companies
...In Japan, Takeda Pharmaceutical slid 2.7 per cent, Astellas Pharma fell 3.9 per cent and Shionogi sank 3.7 per cent on Thursday morning, while in Australia biotech company CSL Ltd dropped 1.4 per cent and...
January 12, 2017
News in-depthUK companies
GSK and AstraZeneca prescribe different treatments
...For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical year....
January 3, 2016
Companies By Region
AstraZeneca adds 55% Acerta Pharma stake to swath of deals
...The investment came a day after AstraZeneca agreed to pay Takeda of Japan $575m for a portfolio of respiratory medicines and a month after it bought ZS Pharma, a US biotech company, for $2.7bn....
December 17, 2015
US & Canadian companies
Otsuka to buy US maker of promising Alzheimer drug
...Cash-rich Japanese drugmakers have been on a spending spree ahead of the so-called “patent cliff”, highlighted by Takeda Pharmaceutical’s $13.7bn purchase of Nycomed, the Swiss drugmaker, in 2011....
December 2, 2014
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
European companies
Japanese drugmakers sit out global M&A party
...Domestic sales at Japan’s five biggest pharmaceuticals groups – Takeda, Astellas Pharma, Daiichi Sankyo, Eisai and Chugai Pharmaceutical – account for between 45 and 90 per cent of revenues....
June 8, 2014
Michael Skapinker
Pharma and Pfizer’s reputations on the line
...But pharmaceutical leaders need to take a hard look at themselves....
May 7, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group....
August 5, 2014
US & Canadian companies
Teva and Sun Pharma fined $2.15bn for patent breach
...Nycomed, now part of Takeda of Japan, owns the rights to the medicine and licensed it exclusively in the US to Wyeth, which is now part of Pfizer....
June 12, 2013
US & Canadian companies
Aspen Pharmacare agrees Merck plant acquisition
...Two year’s later Aspen paid R6.1bn for the pharmaceutical business of Australian-based Sigma Pharmaceuticals to bolster its expansion plans in the Asia Pacific region....
June 27, 2013
Pharmaceuticals sector
Pharma groups hope for diet drugs binge
...Japanese companies have proved more active: Eisai partnered with Arena and Takeda with Orexigen....
December 26, 2012
US & Canadian companies
Bausch & Lomb put up for sale at $10bn
...Bausch & Lomb makes contact lenses, lens care solutions as well as ophthalmic surgical and pharmaceutical products....
December 12, 2012
Global Economy
Cultural shift edges into corporate Japan
...Takeda, the pharmaceuticals group is seen as a good example of this. Its acquisition of Millennium in the US began that change and led to the creation of an internal M&A team based in the US....
October 22, 2012
US & Canadian companies
FDA accuses Amylin of withholding info
...regulator has accused Amylin, the biotech company, of withholding important information on cardiac side effects of its drugs, casting a shadow over competitive bidding for the business by several large pharmaceutical...
June 26, 2012
US & Canadian companies
Sandoz gains dermatology lead with Fougera
...But when the firms sold Nycomed to Takeda Pharmaceutical for $13.7bn last year, they kept Fougera....
May 2, 2012

Previous pagePage 1 of 5Next page